WYE: ANTI-ALZHEIMER'S DRUG SUCCESS

Recently Wyeth has had successful clinical trials that have reduced Alzheimer's disease in mice. This is a huge step as the drug is now being prepared for human testing. Today, it is estimated that about five million Americans suffer from Alzheimer's disease, and about 360,000 people are newly diagnosed every year. Alzheimer's affects about 10 percent of people ages 65 and up, and the prevalence doubles roughly every 10 years after age 65. This is a huge step in the fight against such a horrible disease that affects so many people. Expect this new drug to be extremely popular pending its success in advanced trials. A huge boost to Wyeth on the up.